HOXA-AS3 expression has previously been linked to poor prognosis in patients with hepatocellular carcinoma (HCC) and glioma [8, 9], and at a functional level, it has been shown to promote the proliferative and migratory activity of HCC, glioma, and lung adenocarcinoma cells [8–10]. This evidence concerns the gene PDS5B and glioma.